Edwards Lifesciences Corp. (EW)
NYSE · Common · CUSIP 28176E108
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for EW and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
28176E108
Market Cap
Large Cap
Business: Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives.
Notes: May 07, 2020 -- Stockholders approved the company's plan to execute a 3-for-1 stock split. The split of the company's outstanding shares of common stock will be effected in the form of a stock dividend of two shares of common stock to the holders of record of each share of Edwards' common stock as of the close of business on May 18, 2020. The additional shares will be distributed on May 29, 2020.

Company Contact

CEO
Michael A. Mussallem
CFO
Scott B. Ullem
Headquarters
One Edwards Way, Irvine, CA 92614
Phone
949-250-2500
Fax
949-250-2248
Investor Relations
Mark Wilterding · 949-250-6826 · investor_relations@edwards.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »